SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-20-011170
Filing Date
2020-10-15
Accepted
2020-10-15 08:46:49
Documents
4
Period of Report
2020-10-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tenx_8k.htm 8-K 32256
2 AMENDMENT TO LICENSE AGREEMENT tenx_ex101.htm EX-10.1 56938
3 PRESS RELEASE tenx_ex991.htm EX-99.1 15660
4 IMAGE tenax_logo.jpg GRAPHIC 6280
  Complete submission text file 0001654954-20-011170.txt   115141
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34600 | Film No.: 201240373
SIC: 8731 Services-Commercial Physical & Biological Research